Glenmark looking strong in pharma pack: Gajendra Nagpal, CEO, Unicon Financial Solns

Gajendra Nagpal, CEO, Unicon Financial Solutions, tells ET Now what makes him bullish on the pharma pack.

Is Glenmark Pharmaceuticals just a sector play or do you have any more within the pharma pack that you are bullish on?

Gajendra Nagpal: Pharmaceutical generally is one sector which obviously has been outperforming the market, but there are some good stories also developing with this company.

The stock is ruling at some 22 times of its FY10 multiple. So given the kind of industry that we are into, there is a lot of headroom for this stock to go up. They have done some new launches into generic and branded generic category. That company is again working hard to make sure that they are able to take advantage of the pharmaceutical opportunities which are available. So to that extent, I do believe that Glenmark would give you a decent return over next one year.